节点文献
三氧化二砷对人雌激素受体阴性乳腺癌细胞株作用的研究
【作者】 张琪;
【导师】 裴晓华;
【作者基本信息】 北京中医药大学 , 中医外科学, 2009, 硕士
【摘要】 乳腺癌是全世界妇女中发病率最高的恶性肿瘤,也是临床上最常见的激素依赖性肿瘤。根据ER表型差异,乳腺癌被分为两种:ER阳性乳腺癌和ER阴性乳腺癌。大约2/3乳腺癌患者呈ER阳性,肿瘤细胞生长具有雌激素依赖性,对于这类患者,临床上常采取撤除雌激素的内分泌治疗方法。大约1/3乳腺癌患者为ER阴性,与ER阳性乳腺癌相比,其恶性度较高,对内分泌治疗不敏感,目前尚无理想的治疗方法,预后较差。若能诱导ER阴性乳腺癌细胞凋亡,将为ER阴性乳腺癌患者的治疗开辟新的治疗途径,为这些患者带来希望。三氧化二砷(分子式As2O3)为无机化合物,是中药砒霜的提取物,有剧毒。长期以来As2O3的药用价值被其剧毒性所掩盖。现在随着质控技术的发达和对As2O3实验及临床研究的深入,As2O3在肿瘤治疗方面的临床应用范围越来越广泛。现代药理研究说明,三氧化二砷对白血病和许多实体瘤有不同程度的抑制作用,中医文献也有不少有关砒霜治疗肿瘤的记载。以此为依据,本实验以MDA-MB-435S细胞为研究对象,研究三氧化二砷对雌激素受体阴性乳腺癌细胞株的细胞生长、细胞形态、细胞周期、细胞凋亡及凋亡相关基因的影响情况,探讨三氧化二砷对ER阴性乳腺癌细胞株的作用机制,在中医治疗ER阴性乳腺癌方面开辟了新思路。【目的】以雌激素受体阴性乳腺癌细胞株MDA-MB-435S为研究对象,研究三氧化二砷对MDA-MB-435S细胞增殖、细胞周期、凋亡的影响,并研究其可能的作用机制。【方法】实验分六部分:MTT实验、光镜观察细胞形态、流式PI单染检测细胞周期和凋亡、流式Annexin V/PI双染检测细胞凋亡、免疫组化检测细胞内Bcl-2和Bax表达情况、PI 33342荧光染色观察细胞凋亡。在体外培养雌激素受体阴性乳腺癌细胞株MDA-MB-435S,采用不同浓度连续作用于细胞。通过MTT比色实验,观察不同施加因素对细胞生长的影响,并根据MTT实验结果初步筛选三氧化二砷的作用浓度,在量效曲线1.75-28μg/ml的线性关系范围内,在IC50值为10.47μg/mL上下选取三氧化二砷的加药浓度,设对照组和加药组(1、5、10、15、20μg/ml)进行流式细胞仪技术检测细胞周期及凋亡的变化,根据流式检测结果选取对照组和加药组(0.25、0.5、1、5、10μg/ml)进行免疫组化检测Bcl-2和Bax的变化,并通过PI 33342荧光染色实验观察细胞凋亡情况。【结果】1.大于1.75μg/ml的三氧化二砷能明显抑制MDA-MB-435S细胞生长,在1.75~28μg/ml浓度范围内抑制作用明显(P<0.001),且有剂量依赖效应。2.三氧化二砷可以使MDA-MB-435S细胞周期中的G0-G1期细胞比率增高,G2/M期细胞比率增高,S期细胞比率下降,与对照组比,结果均有显著性差异(p<0.05)。3.流式PI单染结果显示:1、5、10、15、20μg/ml浓度范围内,MDA-MB-435S细胞未见明显凋亡,而MCF-7细胞可见明显凋亡(p<0.05)。4.Annexin V/PI双染结果显示:1、5、10、15、20μg/ml浓度与对照组相比,MDA-MB-435S细胞的早期凋亡率未见显著性差异;0.25、0.5、1、1.5、2μg/ml浓度与对照组相比,MDA-MB-435S细胞的早期凋亡率均有显著性差异(p<0.05),且随加药浓度的增加凋亡率明显增高。说明低浓度三氧化二砷可能诱导MDA-MB-435S细胞凋亡。5.免疫组化结果显示:三氧化二砷组(0.25、0.5、1、5、10μg/ml)与对照组相比,可以下调BCL-2表达和BAX表达。6.PI 33342荧光染色结果显示:相同条件下,三氧化二砷组(0.25、0.5、1、5、10μg/ml)与空白对照组相比,MDA-MB-435S细胞未见明显凋亡细胞形态,MCF-7细胞可见凋亡细胞形态。【结论】1.三氧化二砷作用于MDA-MB-435S细胞可抑制细胞增殖。2.三氧化二砷可阻滞MDA-MB-435S细胞周期在G0-G1和G2-M期,使进入S期细胞减少,可能诱导MDA-MB-435S细胞凋亡。3.三氧化二砷可以下调BCL-2表达和BAX表达,三氧化二砷可能是通过下调BCL-2表达的方式来达到抑制MDA-MB-435S细胞生长的作用,但三氧化二砷对MDA-MB-435S细胞抑制作用的方式有待进一步研究。
【Abstract】 Women breast cancer is the world’s highest incidence of malignant tumor,and is clinically the most common hormone-dependent tumor. According to phenotypic differences in ER breast cancer were divided into two types:ER-positive breast cancer and ER-negative breast cancer.About 2 / 3 were ER-positive breast cancer patients,tumor cell growth with estrogen-dependent.For such patients,clinicians often take estrogen removal of endocrine treatment.Approximately 1 / 3 for ER-negative breast cancer patients with ER-positive breast cancer compared to a higher grade, is not sensitive to endocrine therapy,there is no ideal method of treatment, poor prognosis.If the induction of apoptosis in ER-negative breast cancer will be ER-negative breast cancer patients to open up new therapeutic approaches,in order to bring hope to these patients.As2O3 which is inorganic compounds,is Chinese medicine extract arsenic, having Highly toxic.A long period of time,the medicinal value of As2O3 has been overshadowed by its highly toxic.Now,with advanced quality control technology and deep studies on experimental and clinical of As2O3,its treatment of Cancer Clinical application is more and more wide. Modern pharmacological studies indicated that,As2O3 has varying degrees of inhibition for leukemia and many solid tumors.Chinese medicine also has a lot of literature on the arsenic treatment of documented tumor. In the experiment,we study that arsenic trioxide roles in estrogen receptor-negative breast cancer cell lines MDA-MB-435S of cell growth, cell morphology,cell cycle,apoptosis and apoptosis-related gene effect.We investigate the effect of arsenic trioxide on the ER-negative breast cancer cell lines the role of mechanisms of Chinese medicine treatment in ER-negative breast cancer has opened up new ideas.ObjectiveTo investigate the influence of arsenic on the cell proliferation, mitotic cycle and apoptosis of MDA-MB-435S and discuss the mechanism.MethodThe experiment was divided into six parts:MTT experiment,Light microscope to observe cell morphology,PI-flow single-dye experiments to measure the changes of cell cycle and apoptosis,Streaming AnnexinⅤ/ PI double staining to measure cell apoptosis,Immunohistochemical detection of intracellular Bcl-2 and Bax expression,PI 33342 fluorescent staining of apoptosis.We adopt the role of different concentrations in vitro MDA-MB-435S.The influence of different factors on growth of the cells were observed by MTT colorimetry assay and corresponding densities of As2O3 were screened preliminary by the results.At 1.75-28μg/ml range of linear relationship by dose-response curves,we select corresponding densities of As2O3 at upper and lower of IC50 value.Located the control group and the As2O3 group(1、5、10、15、20μg/ml),we measure the changes of cell cycle and apoptosis by flow cytometry,according to flow test results,we selecte the control group and the As2O3 group(1、5、10、15、20μg/ml) for being detected BCL-2 and BAX changes by immunohistochemical method.Cell apoptosis were observed by PI 33342 fluorescence staining experiments.results1.Greater than 1.75μg/ml arsenic trioxide could significantly inhibit the growth of MDA-MB-435S cells,and arsenic trioxide have a dose effect in 1.75~28μg/ml concentration range(P<0.001).2.Arsenic Trioxide can make the percentage of G0-G1 stage cells and G2/M stage cells increase in the MDA-MB-435S cell cycle,and make S stage cell decrease.To contrast with control group,all of the results have significant differences(p<0.05).3.PI-flow single-dye experiments show that MDA-MB-435S cells do not have obvious apoptosis and MCF-7 cells have obvious apoptosis in 1、5、10、15、20μg/ml(p<0.05).4.Streaming AnnexinⅤ/ PI double staining experiments show that the early apoptosis rate of MDA-MB-435S cells have no significant difference by As2O3 group(1、5、10、15、20μg/ml)compared with control group,and the early apoptosis rate of MDA-MB-435S cells have significant difference by As2O3 group(0.25、0.5、1、1.5、2μg/ml) compared with control group.With the action dose heightening,the rate of Apoptosis will be induced to increase obviously.MDA-MB-435S cells apoptosis probably induced by low concentrations of arsenic trioxide.5.Immunohistochemical detection experiments show that the group of Arsenic Trioxide(0.25、0.5、1、5、10μg/ml) compared with control group can down-regulate the express of BCL-2 and BAX.6.PI 33342 fluorescent staining experiments show that,under the same conditions,the group of Arsenic Trioxide(0.25、0.5、1、5、10μg/ml )compared with control group,apoptotic cells morphology can not be seen obviously in MDA-MB-435S cells and can be seen in MCF-7 cells.conclusion1.arsenic trioxide can inhibit MDA-MB-435S cell proliferation.2.Arsenic trioxide can block MDA-MB-435S cell cycle at G0-G1 and G2-M phase,so that reduction into the S phase cells,probably induced by MDA-MB-435S cell apoptosis.3.Arsenic Trioxide can down-regulate the express of BCL-2 and BAX. Arsenic trioxide are possible through reduced expression of BCL-2 to attain the inhibition MDA-MB-435S cells.Inhibition of the way should be studied further.